JP2011506447A5 - - Google Patents

Download PDF

Info

Publication number
JP2011506447A5
JP2011506447A5 JP2010537971A JP2010537971A JP2011506447A5 JP 2011506447 A5 JP2011506447 A5 JP 2011506447A5 JP 2010537971 A JP2010537971 A JP 2010537971A JP 2010537971 A JP2010537971 A JP 2010537971A JP 2011506447 A5 JP2011506447 A5 JP 2011506447A5
Authority
JP
Japan
Prior art keywords
connexin
agent
polynucleotide
pharmaceutical composition
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010537971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011506447A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/013656 external-priority patent/WO2009075882A2/en
Publication of JP2011506447A publication Critical patent/JP2011506447A/ja
Publication of JP2011506447A5 publication Critical patent/JP2011506447A5/ja
Withdrawn legal-status Critical Current

Links

JP2010537971A 2007-12-11 2008-12-11 損傷した創傷治癒組成物および治療 Withdrawn JP2011506447A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US726207P 2007-12-11 2007-12-11
PCT/US2008/013656 WO2009075882A2 (en) 2007-12-11 2008-12-11 Impaired wound healing compositions and treatments

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014097425A Division JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療

Publications (2)

Publication Number Publication Date
JP2011506447A JP2011506447A (ja) 2011-03-03
JP2011506447A5 true JP2011506447A5 (enExample) 2013-01-31

Family

ID=40626592

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010537971A Withdrawn JP2011506447A (ja) 2007-12-11 2008-12-11 損傷した創傷治癒組成物および治療
JP2014097425A Withdrawn JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療
JP2016082856A Pending JP2016135799A (ja) 2007-12-11 2016-04-18 損傷した創傷治癒組成物および治療

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014097425A Withdrawn JP2014144976A (ja) 2007-12-11 2014-05-09 損傷した創傷治癒組成物および治療
JP2016082856A Pending JP2016135799A (ja) 2007-12-11 2016-04-18 損傷した創傷治癒組成物および治療

Country Status (8)

Country Link
US (1) US20100279921A1 (enExample)
EP (1) EP2245158A2 (enExample)
JP (3) JP2011506447A (enExample)
CN (2) CN102920996A (enExample)
AU (2) AU2008335718A1 (enExample)
CA (1) CA2709153A1 (enExample)
WO (1) WO2009075882A2 (enExample)
ZA (1) ZA201004998B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2662088A3 (en) 2005-02-03 2014-02-19 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
ES2527131T3 (es) 2006-12-11 2015-01-20 Coda Therapeutics, Inc. Polinucleótidos anticonexina como composiciones para la curación alterada de heridas
AU2008343839A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
EP2237795A2 (en) * 2007-12-21 2010-10-13 Coda Therapeutics, Inc. Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions
EP2234656A2 (en) * 2007-12-21 2010-10-06 Coda Therapeutics, Inc. Improved medical devices
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
WO2009085273A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides for the treatment of surgical adhesions
WO2009085271A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions
AU2008343755A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars
CN104271142B (zh) 2012-03-01 2017-07-04 福斯特斯特林研究公司 含有α连接蛋白C‑末端(ACT)肽的局部凝胶
US20140031753A1 (en) * 2012-07-25 2014-01-30 Neil T. Winthrop Thoracostomy devices and methods of use
US9156896B2 (en) 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
WO2015130840A2 (en) * 2014-02-25 2015-09-03 Coda Therapeutics, Inc. Treatment of resistant lesions
JP6683686B2 (ja) 2014-08-22 2020-04-22 オークランド ユニサービシーズ リミティド チャネル調節剤
CN107636003A (zh) * 2015-01-20 2018-01-26 米拉根医疗股份有限公司 miR‑92抑制剂及其用途
WO2018199777A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
CN109513037B (zh) * 2018-11-14 2021-09-17 华中科技大学同济医学院附属协和医院 一种负载介孔生物玻璃的小肠粘膜下层创面敷料
WO2021119198A1 (en) * 2019-12-09 2021-06-17 Cage Bio, Inc. Topical delivery of rna interference agents using ionic liquid
CN111214694B (zh) * 2020-03-31 2022-04-22 山东大鱼生物技术有限公司 一种具有止血和加速伤口愈合功能的敷料及其制备方法
EP4232157A4 (en) 2020-10-22 2024-08-28 Xequel Bio, Inc. PEPTIDE FORMULATIONS AND ASSOCIATED OPHTHALMIC USES

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0539594Y2 (enExample) * 1988-08-05 1993-10-07
US5166195A (en) * 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
CA2361251C (en) * 1999-01-27 2011-03-08 David L. Becker Formulations comprising antisense nucleotides to connexins
US7250397B2 (en) * 2000-02-23 2007-07-31 Zealand Pharma A/S Antiarrhythmic peptides
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
CN1939529A (zh) * 2002-01-29 2007-04-04 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
HUE038099T2 (hu) * 2004-12-21 2018-09-28 Musc Found For Res Dev Kompozíciók és módszerek sebgyógyulás és szöveti regeneráció elõsegítésére
EP2662088A3 (en) * 2005-02-03 2014-02-19 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
JP5960944B2 (ja) * 2006-11-15 2016-08-02 コーダ セラピューティクス, インコーポレイテッド 創傷治癒のための改善された方法および組成物
ES2527131T3 (es) * 2006-12-11 2015-01-20 Coda Therapeutics, Inc. Polinucleótidos anticonexina como composiciones para la curación alterada de heridas
CA2709151A1 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
EP2237795A2 (en) * 2007-12-21 2010-10-13 Coda Therapeutics, Inc. Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions
AU2008343839A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
JP2011507862A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス, インコーポレイテッド 異常瘢痕または過剰瘢痕の治療のための抗コネキシン43ポリヌクレオチドの使用
WO2009085271A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions
EP2240583A2 (en) * 2008-01-07 2010-10-20 Coda Therapeutics, Inc. Wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2011508605A5 (enExample)
RU2009122370A (ru) Улучшенные способы и композиции для заживления ран
JP2011507858A5 (enExample)
JP2011507861A5 (enExample)
JP2025128190A5 (enExample)
JP2022031772A5 (enExample)
JP2011507855A5 (enExample)
CN102718858B (zh) 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
JP2010512404A5 (enExample)
US8975237B2 (en) Treatment of fibrotic conditions
SA517381997B1 (ar) تركيبة لتضميد الجرح
US20110130710A1 (en) Treatment of abnormal or excessive scars
JP2019214592A (ja) ベンダムスチンの製剤
RU2009126594A (ru) Композиции и способы лечения плохо заживающих ран
CN102920996A (zh) 受损伤口愈合的药物组合物
CN104271149A (zh) 经皮递送装置
JP2015083606A (ja) 線維症性の状態の治療のための抗コネキシンポリヌクレオチド剤と組み合わせた抗コネキシンポリペプチド剤の使用
US20110144182A1 (en) Treatment of surgical adhesions
KR20120014251A (ko) 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법
US20140275209A1 (en) Wound healing compositions and treatments
JP6196704B2 (ja) 神経因性疾病の治療のための医薬
CN101896190A (zh) 用α胸腺肽和抗细胞毒性T淋巴细胞相关抗原4(CTLA4)的抗体的组合治疗黑素瘤
AU2006206393A1 (en) Methods for treating adhesive capsulitis
CN102049061A (zh) 一种壳聚糖胶原海绵烧伤敷料的制备方法
WO1996002270A1 (en) Use of insulin-like growth factor in combination with insulin